A multicenter phase 4 geriatric assessment directed trial to evaluate gemcitabine +/- nab-paclitaxel in elderly pancreatic cancer patients (GrantPax).

Johannes BetgeJing Chi-KernNadine SchulteSebastian BelleTobias GuttingElke BurgermeisterRalf JesenofskyMartin MaenzUlrich WeddingMatthias P EbertNicolai Haertel

Published in: BMC cancer (2018)

NCT02812992 , registered 24.06.2016.

Keyphrases

study protocol
phase iii
clinical trial
middle aged
phase ii
advanced non small cell lung cancer
community dwelling
double blind
locally advanced
cross sectional
randomized controlled trial
hip fracture
open label
chemotherapy induced
placebo controlled